PPT Slide

• 6 Standard MHC Tetramers now released

  • 8 in pipeline

• ᡑ Clinical trials under contract, vaccine business accelerating

  • Merck agreement

• Transplantation management (CMV)

  • First patient application

• Market projections : < $100 million by 2005

Immunomics Status

Previous slide

Back to first slide

View graphic version